Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.

Zimmermann C, Kowalewski D, Bauersfeld L, Hildenbrand A, Gerke C, Schwarzmüller M, Le-Trilling VTK, Stevanovic S, Hengel H, Momburg F, Halenius A.

PLoS Pathog. 2019 Sep 17;15(9):e1008040. doi: 10.1371/journal.ppat.1008040. [Epub ahead of print]

2.

The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors.

Železnjak J, Lisnić VJ, Popović B, Lisnić B, Babić M, Halenius A, L'Hernault A, Roviš TL, Hengel H, Erhard F, Redwood AJ, Vidal SM, Dölken L, Krmpotić A, Jonjić S.

J Exp Med. 2019 Aug 5;216(8):1809-1827. doi: 10.1084/jem.20182213. Epub 2019 May 29.

PMID:
31142589
3.

MHC class II proteins mediate cross-species entry of bat influenza viruses.

Karakus U, Thamamongood T, Ciminski K, Ran W, Günther SC, Pohl MO, Eletto D, Jeney C, Hoffmann D, Reiche S, Schinköthe J, Ulrich R, Wiener J, Hayes MGB, Chang MW, Hunziker A, Yángüez E, Aydillo T, Krammer F, Oderbolz J, Meier M, Oxenius A, Halenius A, Zimmer G, Benner C, Hale BG, García-Sastre A, Beer M, Schwemmle M, Stertz S.

Nature. 2019 Mar;567(7746):109-112. doi: 10.1038/s41586-019-0955-3. Epub 2019 Feb 20.

PMID:
30787439
4.

Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Schilling M, Bulli L, Weigang S, Graf L, Naumann S, Patzina C, Wagner V, Bauersfeld L, Goujon C, Hengel H, Halenius A, Ruzsics Z, Schaller T, Kochs G.

J Virol. 2018 Aug 16;92(17). pii: e01056-18. doi: 10.1128/JVI.01056-18. Print 2018 Sep 1.

5.

Improved Ribo-seq enables identification of cryptic translation events.

Erhard F, Halenius A, Zimmermann C, L'Hernault A, Kowalewski DJ, Weekes MP, Stevanovic S, Zimmer R, Dölken L.

Nat Methods. 2018 May;15(5):363-366. doi: 10.1038/nmeth.4631. Epub 2018 Mar 12.

6.

A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle.

Matschulla T, Berry R, Gerke C, Döring M, Busch J, Paijo J, Kalinke U, Momburg F, Hengel H, Halenius A.

Sci Rep. 2017 Jun 7;7(1):2933. doi: 10.1038/s41598-017-02994-5.

7.

Presentation of a Conserved Adenoviral Epitope on HLA-C*0702 Allows Evasion of Natural Killer but Not T Cell Responses.

Keib A, Günther PS, Faist B, Halenius A, Busch DH, Neuenhahn M, Jahn G, Dennehy KM.

Viral Immunol. 2017 Apr;30(3):149-156. doi: 10.1089/vim.2016.0145. Epub 2017 Jan 13.

PMID:
28085643
8.

The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages.

Thiel N, Keyser KA, Lemmermann NA, Oduro JD, Wagner K, Elsner C, Halenius A, Lenac Roviš T, Brinkmann MM, Jonjić S, Cicin-Sain L, Messerle M.

PLoS Pathog. 2016 Dec 7;12(12):e1006057. doi: 10.1371/journal.ppat.1006057. eCollection 2016 Dec.

9.

CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.

Rölle A, Halenius A, Ewen EM, Cerwenka A, Hengel H, Momburg F.

Eur J Immunol. 2016 Oct;46(10):2420-2425. doi: 10.1002/eji.201646492. Epub 2016 Aug 29.

10.

CEACAM1-Mediated Inhibition of Virus Production.

Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E, Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O.

Cell Rep. 2016 Jun 14;15(11):2331-9. doi: 10.1016/j.celrep.2016.05.036. Epub 2016 Jun 2.

11.

Development of Suberin Fatty Acids and Chloramphenicol-Loaded Antimicrobial Electrospun Nanofibrous Mats Intended for Wound Therapy.

Tamm I, Heinämäki J, Laidmäe I, Rammo L, Paaver U, Ingebrigtsen SG, Škalko-Basnet N, Halenius A, Yliruusi J, Pitkänen P, Alakurtti S, Kogermann K.

J Pharm Sci. 2016 Mar;105(3):1239-47. doi: 10.1016/j.xphs.2015.12.025. Epub 2016 Feb 9.

PMID:
26886306
12.

The murine cytomegalovirus immunoevasin gp40 binds MHC class I molecules to retain them in the early secretory pathway.

Janßen L, Ramnarayan VR, Aboelmagd M, Iliopoulou M, Hein Z, Majoul I, Fritzsche S, Halenius A, Springer S.

J Cell Sci. 2016 Jan 1;129(1):219-27. doi: 10.1242/jcs.175620. Epub 2015 Nov 2.

13.

Suberin fatty acids isolated from outer birch bark improve moisture barrier properties of cellulose ether films intended for tablet coatings.

Heinämäki J, Halenius A, Paavo M, Alakurtti S, Pitkänen P, Pirttimaa M, Paaver U, Kirsimäe K, Kogermann K, Yliruusi J.

Int J Pharm. 2015 Jul 15;489(1-2):91-9. doi: 10.1016/j.ijpharm.2015.04.066. Epub 2015 Apr 29.

PMID:
25936623
14.

Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Halenius A, Gerke C, Hengel H.

Cell Mol Immunol. 2015 Mar;12(2):139-53. doi: 10.1038/cmi.2014.105. Epub 2014 Nov 24. Review.

15.

IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Rölle A, Pollmann J, Ewen EM, Le VT, Halenius A, Hengel H, Cerwenka A.

J Clin Invest. 2014 Dec;124(12):5305-16. doi: 10.1172/JCI77440. Epub 2014 Nov 10.

16.

Human cytomegalovirus and autoimmune disease.

Halenius A, Hengel H.

Biomed Res Int. 2014;2014:472978. doi: 10.1155/2014/472978. Epub 2014 Apr 29. Review.

17.

Fast tablet tensile strength prediction based on non-invasive analytics.

Halenius A, Lakio S, Antikainen O, Hatara J, Yliruusi J.

AAPS PharmSciTech. 2014 Jun;15(3):781-91. doi: 10.1208/s12249-014-0104-0. Epub 2014 Mar 18.

18.

A natural tapasin isoform lacking exon 3 modifies peptide loading complex function.

Beutler N, Hauka S, Niepel A, Kowalewski DJ, Uhlmann J, Ghanem E, Erkelenz S, Wiek C, Hanenberg H, Schaal H, Stevanović S, Springer S, Momburg F, Hengel H, Halenius A.

Eur J Immunol. 2013 Jun;43(6):1459-69. doi: 10.1002/eji.201242725. Epub 2013 May 10.

19.

The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.

Urban S, Textoris-Taube K, Reimann B, Janek K, Dannenberg T, Ebstein F, Seifert C, Zhao F, Kessler JH, Halenius A, Henklein P, Paschke J, Cadel S, Bernhard H, Ossendorp F, Foulon T, Schadendorf D, Paschen A, Seifert U.

J Immunol. 2012 Jul 15;189(2):529-38. doi: 10.4049/jimmunol.1101886. Epub 2012 Jun 15.

20.

Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.

Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F, Synaeve C, Deenen R, Ginzel S, Dvorsky R, Gombert M, Halenius A, Hartig R, Helminen M, Fischer A, Stepensky P, Vettenranta K, Köhrer K, Ahmadian MR, Laws HJ, Fleckenstein B, Jumaa H, Latour S, Schraven B, Borkhardt A.

Leukemia. 2012 May;26(5):963-71. doi: 10.1038/leu.2011.371. Epub 2012 Jan 6.

PMID:
22289921
21.

Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.

Verweij MC, Ressing ME, Knetsch W, Quinten E, Halenius A, van Bel N, Hengel H, Drijfhout JW, van Hall T, Wiertz EJ.

Mol Immunol. 2011 Mar;48(6-7):835-45. doi: 10.1016/j.molimm.2010.12.008. Epub 2011 Feb 2.

22.

Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription.

Halenius A, Hauka S, Dölken L, Stindt J, Reinhard H, Wiek C, Hanenberg H, Koszinowski UH, Momburg F, Hengel H.

J Virol. 2011 Apr;85(7):3473-85. doi: 10.1128/JVI.01923-10. Epub 2011 Jan 19.

23.

Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.

Halenius A, Momburg F, Reinhard H, Bauer D, Lobigs M, Hengel H.

J Biol Chem. 2006 Mar 3;281(9):5383-90. Epub 2005 Dec 15.

24.

Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.

Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH.

J Virol. 2005 Mar;79(5):2920-30.

25.

Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?

Santibanez S, Niewiesk S, Heider A, Schneider-Schaulies J, Berbers GA, Zimmermann A, Halenius A, Wolbert A, Deitemeier I, Tischer A, Hengel H.

J Gen Virol. 2005 Feb;86(Pt 2):365-74.

PMID:
15659756
26.

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.

Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S.

J Exp Med. 2005 Jan 17;201(2):211-20. Epub 2005 Jan 10.

27.

Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.

Peltoniemi J, Broberg EK, Halenius A, Setala N, Eralinna JP, Salmi AA, Roytta M, Hukkanen V.

Clin Exp Immunol. 2004 Aug;137(2):305-12.

28.

Hepatitis C virus mutation affects proteasomal epitope processing.

Seifert U, Liermann H, Racanelli V, Halenius A, Wiese M, Wedemeyer H, Ruppert T, Rispeter K, Henklein P, Sijts A, Hengel H, Kloetzel PM, Rehermann B.

J Clin Invest. 2004 Jul;114(2):250-9.

Supplemental Content

Loading ...
Support Center